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ABSTRACT Fasciola hepatica is a parasitic trematode of global importance in live-
stock. Control strategies reliant on anthelmintics are unsustainable due to the emer-
gence of drug resistance. Vaccines are under development, but efﬁcacies are vari-
able. Evidence from experimental infection suggests that vaccine efﬁcacy may be
affected by parasite-induced immunomodulation. Little is known about the immune
response to F. hepatica following natural exposure. Hence, we analyzed the immune
responses over time in calves naturally exposed to F. hepatica infection. Cohorts of
replacement dairy heifer calves (n  42) with no prior exposure to F. hepatica, on
three commercial dairy farms, were sampled over the course of a grazing season. Ex-
posure was determined through an F. hepatica-speciﬁc serum antibody enzyme-
linked immunosorbent assay (ELISA) and ﬂuke egg counts. Concurrent changes in
peripheral blood leukocyte subpopulations, lymphocyte proliferation, and cytokine
responses were measured. Relationships between ﬂuke infection and immune re-
sponses were analyzed by using multivariable linear mixed-effect models. All calves
from one farm showed evidence of exposure, while cohorts from the remaining two
farms remained negative over the grazing season. A type 2 immune response was
associated with exposure, with increased interleukin-4 (IL-4) production, IL-5 tran-
scription, and eosinophilia. Suppression of parasite-speciﬁc peripheral blood mono-
nuclear cell (PBMC) proliferation was evident, while decreased mitogen-stimulated
gamma interferon (IFN-) production suggested immunomodulation, which was not
restricted to parasite-speciﬁc responses. Our ﬁndings show that the global immune
response is modulated toward a nonproliferative type 2 state following natural chal-
lenge with F. hepatica. This has implications in terms of the timing of the adminis-
tration of vaccination programs and for host susceptibility to coinfecting pathogens.
KEYWORDS multivariable regression modeling, natural challenge, parasitology,
veterinary immunology, veterinary vaccine development, zoonotic infections
The liver ﬂuke (Fasciola hepatica) is a parasitic trematode of global importance thatis capable of infecting a wide range of vertebrate hosts, including humans. Fascio-
losis is considered a major issue for global food security, with over 600 million sheep
and cattle thought to be infected worldwide (1). In cattle, the clinical presentation
ranges from severe, acute disease to chronic disease depending on the intensity and
stage of infection, although both types of disease result in signiﬁcant morbidity and/or
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production losses. Subclinical infections reduce weight gain, fertility, and milk yield,
which impacts the economic viability of farm production systems (2, 3) and may last for
months or years if untreated (4).
Both the incidence and prevalence of infection have increased across Europe over
the last decade. This is largely attributed to climatic changes, namely, increases in
ambient temperatures and rainfall, favoring the development of both F. hepatica and
its intermediate snail host, Galba truncatula. As a result, the range and prevalence of
infection are increasing spatially and temporally, with changes in climate being pro-
jected to further increase the prevalence across Europe in the coming decades (5).
The control of fasciolosis in livestock is currently based on a limited number of
anthelmintics, of which triclabendazole (TCBZ) has been the most heavily used due to
its efﬁcacy against both adult and migratory juvenile stages of the parasite (6).
TCBZ-resistant F. hepatica infections in livestock are now widely reported (7–12). There
is therefore a need to develop novel approaches to control fasciolosis, with vaccination
being proposed as a potential adjunctive measure.
Current vaccine trials are focused on several immunodominant parasite antigens,
including cathepsin L proteases, glutathione S-transferase (GST), fatty acid binding
proteins (FABPs), and leucine aminopeptidase (LAP), which have been tried in a number
of formulations and host species (cattle, sheep, and goats) in both native and recom-
binant forms, with levels of protection ranging from 0 to 72% (13, 14). In cattle, as with
other ruminant species, protection is often only partial, with reductions in ﬂuke
burden, egg output, and viability being observed in vaccinated animals compared
to unvaccinated controls (15, 16). In these circumstances, mathematical modeling
has shown that such partial protection must be induced in at least 90% of the herd
to have a meaningful impact on disease control (17).
Where vaccine-induced protection is demonstrated, it has been shown to correlate
with parasite-speciﬁc IgG2 isotype antibody titers and avidity and a reduction in
arginase activity in CD14 blood monocyte-derived macrophages, suggesting that the
presence of a cell-mediated type 1 response is an important component of vaccine-
induced protection against F. hepatica (15, 18). Such responses, however, are not
typically associated with infection in unvaccinated animals.
Epidemiological evidence shows that the prevalence of F. hepatica infection in-
creases with age (19), while chronically infected cattle remain susceptible to superim-
posed experimental infections (20), suggesting an absence of any protective immunity.
Studies investigating the immune responses of cattle experimentally infected with F.
hepatica initially showed a proinﬂammatory response progressing over the course of
infection toward a polarized, nonproliferative state. Parasite-speciﬁc interleukin-2 (IL-2),
IL-4, and gamma interferon (IFN-) production is observed in hepatic lymph nodes at
10 to 14 days postinfection (21), and parasite-speciﬁc IL-2 and IFN- production is also
detected in peripheral blood mononuclear cells (PBMCs) from 1 to 3 weeks postinfec-
tion (wpi), becoming absent by 5 wpi (22, 23). Similarly, mitogen- and parasite-speciﬁc
stimulated PBMC proliferation peaks at around 2 wpi before returning to preinfection
levels (22–25). Thereafter, responses progress toward a nonproliferative state associ-
ated with type 2 cytokines, an IgG1 isotype antibody response, and eosinophilia (20, 24,
26). By 10 to 12 wpi, when the parasite has reached the bile ducts and matured, there
is a lack of mitogen- or parasite-speciﬁc lymphocyte proliferation and an upregulation
of IL-10 and transforming growth factor  (TGF-) (27, 28). It has been suggested that
this ﬂuke-induced modulation of the immune response facilitates its long-term survival
within the host (29) and may also impact the host’s susceptibility to other, coinfecting
pathogens such as Salmonella enterica serovar Dublin (30) andMycobacterium bovis, the
causative agent of bovine tuberculosis (31, 32).
Current vaccine development programs are based on the assumption that immune
responses observed in experimentally infected cattle are representative of those in
naturally infected cattle. However, little is known about the immune responses asso-
ciated with naturally acquired F. hepatica infections, speciﬁcally the early stages of
infection, and the extent to which parasite-induced immunomodulation is induced.
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This may have implications for how vaccines are delivered in the ﬁeld and for under-
standing how this parasite may affect host susceptibility to coinfecting pathogens. The
aim of this study was therefore to deﬁne the immune responses in cohorts of dairy
heifers on United Kingdom farms under typical management conditions and naturally
exposed to challenge with F. hepatica.
RESULTS
Fecal egg counts and antibody responses. All calves remained healthy through-
out the study, with no clinical signs as a result of F. hepatica infection, nematode
burden, or other disease being observed. On each farm, the adult milking herd was
monitored monthly by using a sample of milk from the bulk tank. All three herds tested
positive on every occasion, with bulk milk tank (BMT) antibody values ranging from 33
to 50% positivity, 54 to 61% positivity, and 79 to 114% positivity for farms A, B, and C,
respectively.
Seroconversion was observed in all 17 calves on farm A; percent positivity (PP)
values increased over the course of the study, reaching 37 to 98% at the ﬁnal time point
(Fig. 1). Fluke eggs were detected in 10 of the 17 animals from farm A by the ﬁnal time
point, with counts in all cases of1 egg per g (epg) of feces. Paramphistome eggs were
also observed in low numbers in seven calves at the ﬁnal time point. Six of these calves
were positive for both F. hepatica and paramphistome eggs.
PP values for the cohorts from farms B and C remained negative throughout the
study, except for two animals from farm B that had positive PP values at a single time
point. These PP values were close to the cutoff (20.3 and 24.7%), and samples taken
from these two calves on every other occasion were negative, suggesting that these
results were false-positive results. All calves from farms B and C remained negative for
ﬂuke eggs for the duration of the study.
Low numbers of nematode eggs were detected in calves on all three farms. Only
two positive samples, with counts of 50 epg, were detected on farm A at a single time
point. Both trichostrongyle and Nematodirus species eggs were observed intermittently
in 15/17 calves from farm B from August onwards, and trichostrongyle eggs were
observed intermittently in 4/8 calves from farm C from July onwards.
Immunological correlates of infection. Twenty-three immune and four signalment
parameters were measured monthly for each calf, yielding over 1,100 separate data
points. To analyze these data, we used multivariable linear mixed-effect modeling. Two
response variables were used: (i) the antibody PP value (Ab) was used to indicate
infection progression, and (ii) the change in the antibody value (ΔAb) after serocon-
version was used to indicate the point of ﬁrst exposure and the early stage of infection.
ΔAb was used because the increases in PP values were highest at the point of
seroconversion (Fig. 2).
FIG 1 Antibody PP values of individual animals over the study period for the three dairy farms (farms A to C). The diagnostic positive cutoff value
(PP  20%) is denoted by a horizontal line. Month of sampling denotes the time point for each sequential visit to each farm.
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(i) Association between Ab and immune responses. The outputs from the three
models using Ab as the response variable (lme_1, lme_2, and lme_3) are shown in Table
1. Statistically signiﬁcant positive associations between Ab (response variable) and days
of exposure were found in all three models, showing that the longer the calves were
grazing, the greater the likelihood of infection. A signiﬁcant negative relationship
between Ab and somatic antigen (SomAg)-speciﬁc PBMC proliferation was also ob-
served in all three models.
When data from all three farms were used (lme_1), statistically signiﬁcant negative
associations were found for farms B and C relative to farm A. Statistically signiﬁcant
positive associations were detected for eosinophil and CD8 PBMC counts, and a
negative coefﬁcient was estimated for peripheral blood WC1 cell counts.
When the immune response data from farm A were used (lme_2), there was a
negative association between Ab and concanavalin A (ConA)-induced IFN- production
FIG 2 Change in antibody PP values (ΔAb) over the course of infection for farm A. Positive values indicate
an increase in the Ab PP value from one time point to the next, and negative values denote a decrease
in the Ab PP value compared to that for the previous month. Values from 1 month prior to serocon-
version (1) are considered separately from other seronegative values (ve), as infection may have been
present at this time point, but the animals had not seroconverted. In experimentally infected animals,
seroconversion occurs at 2 to 4 weeks postinfection (42).
TABLE 1Multivariable linear mixed-effect model outputs for anti-F. hepatica antibody PP
values as response variablesa
Model, type of data used
Explanatory
variable (x)
Coefﬁcient
value () SE P value
lme_1, all data Farm B 0.687 0.077 0.001
Farm C 0.874 0.087 0.001
Days of exposure 0.005 0.001 0.001
E/ml 0.0001 0.00004 0.024
CD8 cells/ml 0.0002 0.0001 0.016
WC1 cells/ml 0.0001 0.00004 0.028
SomAg 0.006 0.003 0.024
lme_2, farm A (positive
cohort)
Days of exposure 0.027 0.003 0.001
SomAg 0.012 0.005 0.039
[ConA] IFN 0.0001 0.00006 0.026
[ConA] IL-4 0.0005 0.0002 0.039
[SomAg] IL-5 0.003 0.001 0.012
lme_3, farms B and C
(negative cohorts)
Farm C 0.201 0.086 0.029
Days of exposure 0.004 0.001 0.001
CD4 cells/ml 0.0001 0.00004 0.010
CD8 cells/ml 0.0004 0.0001 0.001
SomAg 0.007 0.003 0.042
aStatistically signiﬁcant (P  0.05) explanatory variables (x) are shown with corresponding coefﬁcient () and
standard error (SE) values to describe their respective relationships with Ab. Values are rounded to 3
decimal places, or 1 signiﬁcant ﬁgure. For cytokine data, brackets indicate which antigen-stimulated culture
condition is referenced, i.e., ConA or SomAg.
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and a positive association with ConA-induced IL-4 and SomAg-induced IL-5 transcrip-
tion.
The model with data from ﬂuke-negative cohorts on farms B and C (lme_3) showed
a signiﬁcant increase in peripheral CD8 T-cell counts and a corresponding decrease in
CD4 T-cell counts.
(ii) Association between Ab and immune responses.When the change in the PP
value (ΔAb) was used to indicate the time of exposure (lme_4) (Table 2), there was a
signiﬁcant negative association between ΔAb and days of exposure, suggesting that
infection occurred early after turnout and that ΔAb is a good measure of early infection.
A negative association was also observed for SomAg-speciﬁc PBMC proliferation, while
positive associations were observed for tegument antigen (TegAg)-speciﬁc PBMC pro-
liferation, ConA-stimulated IL-4 production, and SomAg-stimulated IL-5 transcription.
When seronegative data from all farms were used (lme_5) (Table 2), there was a
signiﬁcant negative association with SomAg-speciﬁc PBMC proliferation and a positive
association with peripheral blood CD8 counts.
Cellular proliferation and cytokine responses. Eosinophil counts increased in all
the animals on all three farms over the course of the study (Fig. 3). PBMC proliferation
responses were variable both between animals and for individual animals at different
time points. The highest parasite-speciﬁc proliferation responses were observed for
animals from farm A.
TABLE 2Multivariable linear mixed-effect model outputs for the change in antibody PP
values as a response variablea
Model, type data used
Explanatory
variable (x)
Coefﬁcient
value () SE P value
lme_4, farm A (postseroconversion) Days of exposure 0.354 0.107 0.004
SomAg 2.794 1.211 0.034
TegAg 2.254 1.064 0.049
[ConA] IL-4 0.012 0.050 0.033
[SomAg] IL-5 0.071 0.029 0.026
lme_5, farms A to C (seronegative values) Farm B 12.009 4.675 0.015
Farm C 14.760 5.096 0.006
CD8 cells/ml 0.027 0.009 0.008
SomAg 0.621 0.276 0.027
TegAg 0.712 0.248 0.005
aStatistically signiﬁcant (P  0.05) explanatory variables (x) are shown with the coefﬁcient () and standard
error (SE) values to describe their respective relationships with ΔAb. Values are rounded to 3 decimal
places. For cytokine data, brackets indicate which antigen-stimulated culture condition is being referenced,
i.e., ConA or SomAg.
FIG 3 Peripheral blood eosinophil counts for individual animals over the study period for the three dairy farms (farms A to C). Month of sampling
denotes the time point for each sequential sampling visit.
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A similar variation was observed for the cytokine responses of animals from farm A.
An increase in ConA-stimulated IFN- production was observed following seroconver-
sion, and there was also evidence of ConA-stimulated IL-4 production. No IFN-
production was detected in response to stimulation with SomAg, while only low levels
of IL-4 production were observed. IL-2 and IL-5 transcription levels were similarly
variable between and within individuals over the course of the study in response to
stimulation with both ConA and SomAg.
No signiﬁcant difference was found between the levels of TGF- expression in early-
and late-stage infections for either medium control or SomAg-stimulated PBMC cul-
tures (P  0.791 and 0.828, respectively), nor was any signiﬁcant difference found
between TGF- levels in medium control and SomAg-stimulated cultures at either time
point (P  0.291 and 0.306, respectively).
DISCUSSION
In this study, we demonstrate that dairy calves develop a polarized, nonproliferative
type 2 response following primary natural challenge with F. hepatica. Previous studies
using experimentally infected calves described an initial inﬂammatory response com-
prised of mixed-cytokine (IFN- and IL-4) production and antigen-speciﬁc proliferation
in PBMC cultures, which subsides at 4 to 6 weeks postinfection. Thereafter, parasite-
speciﬁc IgG1 and IL-4 responses are detected, indicating polarization toward a type 2
immune response as infection progresses (20, 22, 23, 33). Our analysis of naturally
infected calves shows an association with increased eosinophil counts, IL-4 production,
and IL-5 transcription and decreased IFN- production, indicating polarization toward
a type 2 response as infection progresses. Furthermore, the increased IL-4 and de-
creased IFN- production by ConA-stimulated PBMCs suggest that polarization of the
global T-cell response is present. This is consistent with previous ﬁndings in experi-
mentally infected cattle (32, 34). The presence of a generalized type 2 immune
environment may help explain why calves are less able to respond effectively to
coinfecting pathogens. For example, cattle infected with F. hepatica are more suscep-
tible to Salmonella Dublin infection (30, 32).
Our ﬁndings differ from those obtained from experimentally infected calves, how-
ever, in the rate and stage at which immune modulation is observed. Experimentally
infected cattle have increased IL-2 and IFN- production in the ﬁrst 2 to 3 weeks
postinfection (22, 23), while our study suggests that the early stages of natural infection
are associated with increased IL-4 production and IL-5 transcription. Similarly, D. G.
Clery and G. Mulcahy (22) showed parasite-speciﬁc proliferation within 2 to 3 weeks
postinfection in experimentally infected calves, while our study detected a signiﬁcant
negative association between SomAg-speciﬁc PBMC proliferation at all stages of infec-
tion. Early proliferative responses were observed in only 3/17 animals. For this study,
samples were taken monthly; hence, some transient early proinﬂammatory responses
may have been missed. Nonetheless, our ﬁndings suggests that, unlike experimental
infections, polarization of the immune response in naturally acquired infection is
present very early during infection.
These differences may relate to the infectious challenge administered in experimen-
tal infections compared to those encountered under ﬁeld conditions. Most experimen-
tal infections have used either a single-dose or a “trickle”-type infection, where boluses
of several hundred to up to 1,000 metacercariae are administered per dose (26, 35). The
epidemiology of F. hepatica in temperate regions typically results in small numbers of
metacercariae being present on pastures early in the spring, followed by increasing
numbers of metacercariae appearing on pastures toward the end of the grazing season
(36). Hence, the administration of a large infectious challenge to immunologically naive
cattle may not be representative of normal ﬁeld conditions and may result in a more
profound innate cellular response during the early stages of experimental infection.
Our results suggest that challenge at the start of the grazing season was not
associated with detectable proinﬂammatory or proliferative responses. The immune
modulation induced during this primary challenge may also prevent any subsequent
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proinﬂammatory, proliferative responses developing later in the season when animals
are exposed to a more substantial infectious challenge as pasture contamination
increases. These ﬁndings have implications for vaccine programs, since current efforts
are focused on enhancing cell-mediated type 1 responses (15, 18). Our results suggest
that the efﬁcacy of such vaccines would be negatively impacted if they were admin-
istered following natural exposure to F. hepatica under ﬁeld conditions. These vaccines
would therefore need to be administered and be fully effective prior to any exposure
to infection.
In experimentally infected calves, a systemic regulatory response develops during
the chronic stages of infection, characterized by increased parasite-speciﬁc IL-10 and
TGF- production by PBMCs (27). In this study, we found no signiﬁcant association
between infection status and parasite-speciﬁc IL-10 or TGF- production by PBMCs.
Again, this may relate to differences in the ways in which the calves were exposed to
infection, although it is possible that such regulatory responses were present in local
inﬂammation and regional lymph nodes, as this was observed previously for cattle and
sheep harboring naturally acquired, chronic F. hepatica infections (28, 37).
Eosinophilia is a feature of many helminth infections. Calves on farm A were treated
with three doses of ivermectin over the course of the grazing season, and nematode
egg counts remained at or close to zero throughout the study period. The eosinophilia
observed in this cohort was most likely a response to F. hepatica rather than nematode
infection, particularly since there was a signiﬁcant positive relationship between ﬂuke
Ab PP values and both peripheral eosinophil counts and SomAg-stimulated IL-5
transcription. This is consistent with previous ﬁndings of eosinophilia in F. hepatica-
infected cattle (26, 38).
Both ﬂuke infection and speciﬁc ﬂuke antigens are known to have immunosuppres-
sive and/or modulatory effects on both the innate and adaptive immune responses (20,
27, 33, 39). Differences between the relationships of SomAg and TegAg PBMC prolif-
eration and the early stages of F. hepatica exposure (ΔAb) may be the result of
differences in the compositions of these two antigen fractions and their functions in
vivo. Overall, however, our results show that in naturally infected calves, there is an
absence and/or suppression of parasite-speciﬁc T-cell proliferation.
The negative relationship between Ab and WC1 PBMC counts is most likely to be
due to age and the maturation of the immune system. Numbers of WC1 T cells are
known to be decreased in the peripheral blood as cattle mature. WC1 cell populations
constitute approximately 15% of PBMCs in calves aged 3 to 12 months, decreasing to
around 5% by 3 years of age (40). In our study, animals ranged in age from 90 to 377
days at the beginning of the study and were 310 to 587 days of age by the end of the
study. The respective mean WC1 PBMC counts were 20% (6 to 32%) and 6% (0.5 to
24%). Similarly, the positive relationship between Ab and CD8 PBMC counts may also
signify the normal maturation of the immune system rather than a direct impact of
infection, since this was also observed in uninfected animals.
In spite of evidence from the adult milking herd showing that F. hepatica infection
was present on all three farms, the calves on farms B and C showed no evidence of
infection. In both cases, these calves were kept in different parts of the farm and did not
share pastures with the adult cows. In contrast, the cohort on farm A was managed in
a rotational grazing system that included pastures grazed by adult cattle. This suggests
that the ﬁelds used for calves on farms B and C had no habitat suitable for the
intermediate host, Galba truncatula, and were not contaminated with metacercariae.
In this study, multivariable linear mixed-effect regression models were used to
analyze a longitudinal set of data from cattle naturally exposed to F. hepatica. This
analysis was useful since it allowed the simultaneous assessment of multiple immuno-
logical variables to identify the key parameters associated with infection. To the best of
our knowledge, this is the ﬁrst time that such techniques have been used to analyze
complex immunological responses to natural infection in livestock and may represent
a potentially useful template for future studies.
In conclusion, by analysis of a longitudinal data set using multivariable linear
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mixed-effect regression analysis, we have demonstrated that natural exposure to F.
hepatica in dairy heifers results in a generalized type 2 immune state with the
concomitant suppression of proliferation responses. This has signiﬁcance for both
vaccine administration programs and susceptibility to other common coinfecting
pathogens of livestock.
MATERIALS AND METHODS
Three commercial dairy farms were recruited for this study. These farms were identiﬁed as being F.
hepatica positive through BMT antibody enzyme-linked immunosorbent assay (ELISA) results (41) and
positive composite fecal egg counts in adult cattle. On each farm, cohorts of replacement dairy heifer
calves were recruited (n  42; 17, 17, and 8 animals from farms A, B, and C, respectively) and were 90
to 377 days of age (mean, 218.5 days; standard deviation [SD], 62.0 days). These animals had been
housed since birth, so they had not been exposed to F. hepatica. This was conﬁrmed prior to turnout by
fecal ﬂuke egg counts and an anti-F. hepatica IgG serum antibody ELISA (42). Negative ELISA results
indicated that no maternally derived antibodies were detectable at turnout.
Animals were sampled monthly over the course of their ﬁrst grazing season from turnout in spring
(April to May) through to housing in autumn (October to November) of 2013. On each occasion, blood
was collected via jugular venipuncture into plain and EDTA-coated vacutainers, and fecal samples were
collected rectally. BMT samples were also taken at each visit to assess changes in levels of exposure
within the milking herd.
All the procedures used in this study were approved by the University of Liverpool Veterinary
Research Ethics Committee (VREC100) and adhered to the conditions of the project license granted by
the United Kingdom Home Ofﬁce (HOL PPL40/3621). All farm data were stored in accordance with the
United Kingdom Data Protection Act (1998).
F. hepatica serum and BMT IgG antibody ELISA. Tubes containing clotted blood were centrifuged
at 2,000  g for 5 min, and serum was collected, stored at 4°C, and tested for ﬂuke-speciﬁc antibody
within 5 days. A positive cutoff of 20% positivity was used, giving a diagnostic sensitivity of 95% and a
speciﬁcity of 99% (42). BMT samples were analyzed by using a PP cutoff value of 27%, giving a
diagnostic sensitivity of 96% and a speciﬁcity of 80%, as described previously (41).
Fluke egg counts. Fecal samples were stored at 4°C prior to analysis and examined for evidence of
F. hepatica eggs according a standard sedimentation technique using 10 g of feces (43). This was
performed on individual samples from the point of seroconversion onwards, with counts being done for
every animal at the ﬁnal time point irrespective of whether they had seroconverted. Nematode infections
for all animals at each time point were assessed by fecal egg counts using the McMaster method, with
a sensitivity of 50 epg (44).
Preparation of F. hepatica antigens. Adult F. hepatica tegument and somatic antigen fractions for
use in in vitro PBMC stimulation assays were prepared by using previously described methods (23, 45);
live adult ﬂukes were collected from infected livers, incubated overnight to purge cecal contents, and
then washed three times in Dulbecco’s phosphate-buffered saline (D-PBS) (Sigma-Aldrich, St. Louis, MO,
USA).
TegAg was prepared by placing ﬂukes in D-PBS with 1% Nonidet P-40 (BDH Chemicals, Poole, UK),
at 1 ml per ﬂuke, and agitating the mixture for 1 h at 4°C. Pierce Detergent Removal spin columns
(Thermo Fisher Scientiﬁc, Waltham, MA, USA) were used to remove the Nonidet P-40 detergent.
SomAg was prepared from tegument-depleted ﬂukes. These ﬂukes were washed in ice-cold D-PBS
and snap-frozen overnight at 80°C. Flukes were then homogenized and diluted in D-PBS, at 0.5 ml per
ﬂuke, and left to settle overnight at 4°C. The supernatant was collected and centrifuged at 12,000  g
for 30 min at 4°C.
Both antigens were ﬁlter sterilized and shown to contain negligible levels of endotoxin at tissue
culture concentrations (Thermo Fisher Scientiﬁc) (46). Protein concentrations were estimated by using a
Bradford assay (Thermo Fisher Scientiﬁc), and aliquots were stored at 80°C.
Hematology, PBMC puriﬁcation, and ﬂow cytometry. Total and differential leukocyte counts were
performed on EDTA-treated whole blood using a hemocytometer and thin blood smears, respectively,
and used to calculate absolute counts for each leukocyte phenotype per milliliter of blood.
PBMCs were isolated from whole blood in a lateral ﬂow hood using Optiprep (Sigma-Aldrich, St.
Louis, MO, USA) according to the manufacturer’s recommendations. Optiprep was added to, and mixed
with, EDTA-treated whole blood, at 1.3 ml of Optiprep per 10 ml of blood, in a 50-ml Falcon tube, onto
which 1 ml 20 mM Tricine-buffered saline was layered. Samples were centrifuged at 1,000 g for 35 min
at 20°C with the brake off, after which the middle aqueous layer containing PBMCs was harvested and
washed in PBS with 0.1% EDTA (Lonza, Basel, Switzerland) to a maximum volume of 20 ml. Samples were
centrifuged at 350 g for 8 min at 20°C. The resulting supernatants were discarded, and cell pellets were
resuspended in 2 ml of 0.9% NH4Cl hemolysis buffer and gently agitated for 1 min at room temperature.
Samples were then washed in 20 ml PBS–EDTA and centrifuged at 150  g for 8 min at 20°C twice, with
puriﬁed PBMCs then being resuspended and prepared for ﬂow cytometry, proliferation, and cytokine
assays, as described previously (47).
One-color indirect immunoﬂuorescence labeling was performed on PBMCs as previously described
(47), with lineage-speciﬁc monoclonal antibodies to identify bovine CD4 and CD8 (48), WC1 (49), and
CD14 (50) subsets. Subpopulations of leukocytes were analyzed by using a MACSQuant analyzer
(Miltenyi Biotech Ltd.). PBMCs were isolated through gating of forward- and side-scatter channels, with
adjustments being made by using a post hoc analysis template (MACSQuantify v.2.4.1221.1; Miltenyi
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Biotech Ltd.) to ensure an appropriate ﬁt for all samples. Leukocyte subpopulations were identiﬁed and
quantiﬁed through ﬂuorescein isothiocyanate (FITC)-positive ﬂuorescence emission and used to calculate
absolute counts per milliliter of blood.
Proliferation and cytokine measurements. PBMCs were adjusted to a concentration of 2  106
cells per ml in RPMI with 10% fetal calf serum (FCS) and 100 g/ml penicillin and streptomycin and
incubated in vitro with either ConA (5 g/ml) or F. hepatica SomAg or TegAg (both at 25 g/ml) or as
unstimulated medium controls to assess proliferative and cytokine responses. For proliferation assays,
2  105 cells per well were cultured in triplicate in 96-well U-bottomed plates (Corning Life Sciences,
USA) for 5 days at 37°C in 5% CO2. On the ﬁfth day, cultures were pulsed with 1 Ci of 3H-labeled tritiated
thymidine (PerkinElmer, Boston, MA USA) for 5 h and then harvested onto glass ﬁlter mats and
embedded in scintillation wax (PerkinElmer, Boston, MA, USA). Beta-particles were measured with a
MicroBeta2 plate counter (PerkinElmer, Boston, MA USA). The stimulation index (SI) of mitogen/antigen-
stimulated cultures was calculated as the fold increase in emission counts compared to those of medium
controls. If the SI for the ConA positive control was 2, proliferation values for both mitogen- and
antigen-stimulated cultures were excluded from further analysis.
For cytokine assays, PBMCs were incubated with ConA (5 g/ml) or SomAg (25 g/ml) or as
unstimulated medium controls for 48 h at 37°C in 5% CO2 in ﬂat-bottomed 24-well cell culture plates
(VWR, Radnor, PA, USA). Upon completion, culture supernatants were removed and stored at20°C, with
PBMCs being stored separately at 20°C in RNAlater (Sigma-Aldrich, St. Louis, MO, USA).
Cytokine production and transcription assays. Cytokine production and transcription were mea-
sured in animals that seroconverted (farm A).
IFN- and IL-4 concentrations in supernatants were measured by using commercially available ELISAs
according to the manufacturer’s protocols (catalog no. MCA5638KZZ and MCA5892KZZ, respectively;
AbD Serotec, Raleigh, NC, USA). IL-10 production in SomAg-stimulated and medium control cultures was
measured by using a previously validated sandwich ELISA (51).
Paired samples were used to investigate differences in TGF- production in early versus chronic
infections; samples for each individual animal were selected at the closest available time point to
seroconversion to represent early infection and from the last available time point to represent chronic
stages of infection. Bioactive bovine TGF- in SomAg-stimulated and medium control cultures was
measured by using a commercially available ELISA kit according to the manufacturer’s recommendations
(Promega, Madison, WI, USA) (52).
Quantitative real-time PCR (qPCR) was used to measure IL-2 and IL-5 mRNA levels against 28S
housekeeper gene transcription in cultured PBMCs by using previously reported primers (NCBI accession
no. AF154866, M12791, and EU915048.1, respectively). RNA extraction was performed by using the
RNeasy minikit (Qiagen, Limburg, Netherlands), and the mRNA level was quantiﬁed with RiboGreen
(Invitrogen Life Technologies, Grand Island, NY, USA). Genomic DNA digestion and cDNA synthesis were
then performed on 1 g of the mRNA template for each sample by using a QuantiTect reverse
transcriptase kit (Qiagen, Limburg, Netherlands). qPCR analysis was performed by using a standard
protocol with SYBR green (Bioline Reagents Ltd., London, UK), as described previously (53).
Samples were assayed alongside known concentration standards diluted in a 10-fold series in 100
ng/l yeast tRNA (Invitrogen Life Technologies, Grand Island, NY, USA) to prevent aggregation. Reactions
were performed by using a DNA Engine Opticon 2 continuous ﬂuorescence detector.
A ﬁnal melting curve analysis was performed from 50°C to 95°C to conﬁrm the speciﬁcity of the
ampliﬁcation products. Sample copy numbers were determined by using linear regression of standard
concentrations following adjustment of threshold cycle (CT) cutoff values to the log-linear phase of
ampliﬁcation. Results for IL-2 and IL-5 transcription are shown as relative expression levels against the
value for the 28S housekeeper gene (per million copies).
Statistical analysis. Data analysis was performed by using multivariable linear mixed-effects models
in the “nlme” package (54) in the R statistical software environment (55). Response variables (Y) chosen
as indicators of exposure to F. hepatica were the antibody PP value (Ab) to assess responses over the
course of infection and the change in PP values (ΔAb) to examine immunological parameters associated
with the early stages of infection. This approach was taken because while PP values (Ab) increased over
the course of the study (Fig. 1), the greatest changes in PP values (ΔAb) were seen at or soon after
seroconversion (Fig. 2).
Details of the structure of each statistical model are shown in Table 3. For all models, leukocyte
counts; PBMC proliferative responses; farm location; and animal age, weight, and days of exposure (days
at pasture) were modeled as ﬁxed effects (Table 3), with individual animal identity being modeled as a
random effect to account for the increased relatedness of responses measured in the same animal.
Models containing data from the ﬂuke-infected cohort (farm A) only (lme_2 and lme_4) (Table 3) were
analyzed to allow the inclusion of the ex vivo PBMC cytokine responses measured as explanatory
variables, thereby giving a more in-depth analysis of the immune responses present in these animals.
Raw immunological data are summarized in the supplemental material (Fig. S1 to S6).
Three models were produced by using Ab as the response variable (lme_1, lme_2, and lme_3) (Table
3). The ﬁrst analysis (lme_1) included all data for all three farms over the 7-month sampling period. Model
lme_2 included data from the ﬂuke-infected cohort (farm A) only. Model lme_3 included data from
ﬂuke-negative cohorts (farms B and C) only.
For analysis of immune responses associated with ΔAb, data collected pre- and postseroconversion
were considered separately to allow the small changes in PP values associated with preseroconversion
and late-stage infection to be considered separately. Consequently, two models were produced by using
ΔAb as the response variable (lme_4 and lme_5) (Table 3). Model lme_4 used postseroconversion data
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from the ﬂuke-positive cohort (farm A) to measure changes in immune responses associated with early
exposure, while model lme_5 used seronegativity data from farms A to C.
Models containing only data from seronegative measurements (lme_4 and lme_5) served to inves-
tigate potential physiological and/or age-related changes, thus avoiding incorrectly attributing such
observations to F. hepatica exposure.
Prior to the linear mixed-model analysis, the relationship between response and ﬁxed-effect explan-
atory variables was assessed, using a Box-Cox transformation (56), with power  being determined by
maximum likelihood (ML) analysis used to transform the response variable to ensure an appropriate
linear relationship (Table 3) (57).
For models with Ab as the response variable (Y), an autoregressive correlation matrix of order 1 was
also used to account for the relatedness of measurements resulting from repeated sampling and, in
particular, the fact that measurements taken close together in time are likely to be more similar than
those taken further apart in time.
Model reﬁnement was then carried out by using a stepwise Akaike information criterion (AIC)
selection method (58), using complete case data for all models being compared with MLs using the
“MASS” package. The criterion of a reduction in the AIC value of 2 was deemed indicative of model
superiority (Table 3). The selected model was then ﬁt to all data for which complete observations were
available by using restricted maximum likelihoods (REMLs). This ﬁnal model was checked for goodness
of ﬁt and normality by using residual analysis and normality plots, respectively (see Fig. S7 and S8 in the
supplemental material). Missing values were considered to be “dropouts completely at random” (DCAR),
since animals were moved between management groups throughout the grazing season for unrelated
reasons (e.g., stocking density and pasture management, etc.) (59).
Model outputs were interpreted by inspecting the coefﬁcient () and associated standard error for
each explanatory variable (x) included in the ﬁnal model. The estimated coefﬁcients indicated whether
a positive or negative relationship was present between each explanatory variable (x) and the (trans-
formed) response variable (Y), once all other explanatory variables present in the analysis had been taken
into account.
To assess TGF- expression in early- versus late-stage infection, results were analyzed by using
two-tailed paired t tests. Differences in measurements between the medium control and SomAg-
stimulated PBMC cultures for each time point were analyzed by using unpaired two-tailed t tests.
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